CardiaTec

Focus: CardiaTec is a UK-based biotechnology company specializing in multiomic maps for therapeutic discovery, positioned as a platform technology provider rather than a traditional drug developer.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About CardiaTec

AI assessmentNot Hiring

No open roles listed right now. Follow CardiaTec to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Evaluation of a New Non-Invasive Device for Detection of Endothelial Dysfunction

Endothelial Dysfunction

N/A

Clinical Trials (1)

NCT00650741Evaluation of a New Non-Invasive Device for Detection of Endothelial Dysfunction

N/A

Help build intelligence for CardiaTec

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage platform technology with potential to unlock novel therapeutic targets across multiple disease areas via multiomics approach
Cambridge location offers access to world-class academic networks and biotech ecosystem talent
Ground-floor opportunity to shape discovery methodologies and establish company culture during formative growth phase

Watch Out For

Pre-revenue status with unknown financial runway; no hiring signals or open roles currently listed despite public company status
Minimal clinical validation—only 1 active trial in non-invasive device space, not traditional drug development, suggests platform maturity questions
Lack of published financials, employee count, and hiring transparency creates significant uncertainty about organizational scale and stability

Generated by Claude from CardiaTec's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

Publications: 2 in PubMed

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Research Publications(2)

Recent peer-reviewed publications with author affiliations at this company

Advancing understanding of long COVID pathophysiology through quantum walk-based network analysis.

Bioinformatics advances

2026

PMID:41816007

Utilising multi-modal data-driven network analysis to identify monotherapy and combinational therapy targets in SOX2-dependent squamous cell lung cancer.

Communications chemistry

2025

PMID:41388088